Latest Regulatory Developments News

Optiscan Imaging Limited has launched a $17.75 million fully underwritten entitlement offer to fund clinical trials, regulatory approvals, and product development. Peters Investments underwrites the offer, potentially increasing its stake to nearly 39%.

Basin Energy Limited has secured $1.25 million to advance exploration of uranium and rare earth metals across strategic Tier-1 jurisdictions, positioning itself amid rising global demand for clean energy minerals.

Horizon Oil and its partners have secured a ten-year extension for the Maari oilfield permit in New Zealand, enabling continued production and strategic planning through 2037. This comes as the field hits its highest output in over five years.

Neuren Pharmaceuticals reported a robust half-year with an 88% increase in net profit, driven by rising royalties from DAYBUE™ sales and progress in its NNZ-2591 clinical program. The company also completed a $39.6 million share buy-back, underscoring confidence in its growth trajectory.

Perpetual Credit Income Trust reported a 20.7% increase in net assets to $532.8 million for FY25, while posting a modest profit decline amid challenging market conditions. The Trust’s $93 million capital raise and diversified credit portfolio underpin its strategy for stable income and growth.

Coast Entertainment Holdings Limited reported a robust FY25 with record revenue and EBITDA growth, driven by strong visitor numbers and the successful launch of new attractions. The company’s momentum continues into FY26 amid ongoing macroeconomic challenges.

Regis Resources Limited delivered a standout FY25 with record revenue and profit, driven by unhedged gold sales and underground growth, while confronting a significant legal challenge over its McPhillamys Gold Project.

SkyCity Entertainment Group reports a 5% revenue decline in FY25 amid economic headwinds and elevated investments, announcing a $240 million equity raise to bolster its balance sheet ahead of the NZICC opening and online gaming launch.

Transurban reports solid FY25 financial results with strong EBITDA and free cash flow growth, steady operating costs, and promising progress on NSW Toll Reform and major infrastructure projects.

APA Group delivered robust FY25 financial results with earnings near the top of guidance and announced confident FY26 growth plans, underpinned by cost reductions and a $2.1 billion project pipeline.

Challenger Limited reported a solid 9% rise in normalised NPAT to $456 million for FY25, alongside an 11% dividend increase to 29.5 cents per share, underscoring its strategic momentum and capital strength. The company’s outlook for FY26 remains positive, with guidance pointing to continued growth and shareholder returns amid evolving retirement income reforms.

Peak Rare Earths Limited has entered a scheme of arrangement with Shenghe Resources (Singapore) Pte. Ltd., valuing the company at approximately A$158 million. The scheme offers Peak shareholders a cash consideration of no less than A$0.359 per share, representing a 199% premium to the last closing price.